• Tue. Dec 1st, 2020

Benzodiazepine

  • Home
  • FDA’s Ok to Roche’s Oral SMA Therapy; Roche’s Etrolizumab Mixed Results in Ulcerative Colitis; Secura receives rights to Copiktra from Verastem

FDA’s Ok to Roche’s Oral SMA Therapy; Roche’s Etrolizumab Mixed Results in Ulcerative Colitis; Secura receives rights to Copiktra from Verastem

Roche Set to Compete With Biogen and Novartis in the SMA Market With its First Oral Therapy  The US FDA has recommended the use of Evrysdi (risdiplam), a candidate of…

Celiac Disease: The Hidden Epidemic of Gluten Sensitivity

The contribution of key pharma companies, such as 9 Meters Biopharma, ImmunogenX, Provention Bio, Cour Pharmaceuticals/Takeda, Precigen ActoBio, Falk Pharma, and Zedira is significant in driving Celiac disease market size.…

Sanofi acquires Principia; FDA’s Nod to Roche’s Enspryng; BMS, Dragonfly’s Licensing Deal

New strategy, new outlook: Sanofi takes another step, gains full control over the Principia’s MS treatment  Sanofi has inked a definitive agreement with Principia Biopharma to acquire the company, all…

Roche Gets U.S. Approval For Enspryng, Takes On Alexion’s Soliris

In the previous few years, Canadian Pharmacy has carved a distinct segment for itself in the market. Investing in pharmaceutical shares based mostly upon patent expirations is not for novices.…

Health Care Staff Of Coloration Almost Twice As Doubtless As Whites To Get COVID

A newly described illness occurring in youngsters and linked to COVID-19 has important adjustments in white blood cells—a discovery that will permit doctors to raised assess their younger patients’ situation…